2m 2m 2m 2m 2m 2m 2m
TUHURA BIO (HURA)
NASDAQ
$2.17+$0.05 (+2.41%)
Price as of Jun 03, 2026 7:55 PM EDT- $143.9MMarket Cap
- -24.82%1-Year Change
- BiotechnologyIndustry
TUHURA BIO (HURA)
$2.17+$0.05 (+2.41%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -20.5M +53.97% | -13.3M +43.22% | -9.3M -38.63% | -15.2M +28.42% | |
Depreciation and Amortization Expense | 71,265 -38.94% | 116,710 -96.38% | 3.2M +161,150.00% | 2,000 0.00% | |
Total Operating Expenses | 31.8M +80.15% | 17.6M +19.29% | 14.8M -34.77% | 22.7M +159.43% | |
Operating Profit | -30.1M +38.60% | -21.7M +48.01% | -14.6M -35.36% | -22.7M -40.83% | |
Interest Income | 136,233 -62.33% | 361,632 N/A | N/A N/A | N/A N/A | |
Interest Expense | -625,283 -84.89% | -4.1M N/A | N/A N/A | -30,000 0.00% | |
Interest Income and Expense and Net | -489,050 -87.05% | -3.8M N/A | 0 +100.00% | -30,000 0.00% | |
Total Nonoperating Income and Expense | 1.7M +143.24% | -4.0M -2,843.41% | 147,000 +600.00% | 21,000 +115.91% | |
Income before Taxes | -30.1M +32.72% | -22.6M +50.81% | -15.0M -40.24% | -25.1M -39.45% | |
Income Taxes | 1,600 -57.54% | 3,768 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -30.1M +38.60% | -21.7M +48.01% | -14.6M -35.36% | -22.7M -40.83% | |
Net Income from Continuing Operations Applicable to Common | -30.1M +32.72% | -22.6M +50.81% | -15.0M -40.24% | -25.1M -39.45% | |
Basic EPS and Net Income | -0.63 -47.93% | -1.21 -86.95% | -9.27 +1,682.69% | -0.52 -67.50% | |
Diluted EPS and Net Income | -0.63 -47.93% | -1.21 -86.95% | -9.27 +1,682.69% | -0.52 -67.50% | |
Basic Weighted Average Shares | 47.9M +156.81% | 18.7M +1,052.02% | 1.6M -96.67% | 48.7M +88.14% | |
Diluted Weighted Average Shares | 47.9M +156.81% | 18.7M +1,052.02% | 1.6M -96.67% | 48.7M +88.14% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.6M -71.40% | 12.7M +724.57% | 1.5M -86.97% | 11.8M +11.80% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.6M -71.40% | 12.7M +724.57% | 1.5M -86.97% | 11.8M +11.80% | |
Total Current Assets | 4.6M -76.44% | 19.6M +499.71% | 3.3M -75.34% | 13.3M +12.42% | |
Accumulated Depreciation | 2.2M +3.41% | 2.1M N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 300,639 +143.70% | 123,366 -82.60% | 709,000 +687.78% | 90,000 -40.00% | |
Total Long-Term Assets | 33,769 0.00% | 33,769 -95.24% | 709,000 +687.78% | 90,000 -61.70% | |
Total Assets | 27.4M +36.99% | 20.0M +401.80% | 4.0M -75.05% | 15.9M +17.76% | |
Income Taxes Payable | 197,919 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 279,000 -6.38% | 298,000 -58.67% | 721,000 +28.52% | |
Total Current Liabilities | 5.9M +11.06% | 5.3M +72.94% | 3.1M -22.76% | 4.0M +43.53% | |
Total Long-Term Debt | 1.4M -40.65% | 2.3M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 699,465 +1,538.17% | 42,698 -98.90% | 3.9M -44.50% | 7.0M N/A | |
Total Liabilities | 6.4M +19.51% | 5.4M +65.42% | 3.2M -21.79% | 4.2M +40.21% | |
Retained Earnings | -141.2M +27.05% | -111.1M -26.59% | -151.4M +11.01% | -136.4M +22.59% | |
Total Stockholders Equity | 20.9M +43.43% | 14.6M +1,896.44% | 731,000 -93.80% | 11.8M +11.47% | |
Total Shares Outstanding | 59.3M +40.20% | 42.3M +2,323.47% | 1.7M -97.34% | 65.5M +100.16% | |
Cash Flow | |||||
Cash from Operating Activities | -27.6M +87.59% | -14.7M +24.13% | -11.9M -41.82% | -20.4M +8.12% | |
Capital Expenditures | 76,083 +31.39% | 57,906 -75.04% | 232,000 +2,800.00% | 8,000 0.00% | |
Cash from Investing Activities | -1.3M -77.94% | -6.1M +2,508.80% | -232,000 -124.07% | 964,000 0.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19.9M -33.07% | 29.8M +1,507.60% | 1.9M -91.44% | 21.6M -16.92% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -127.02% -29.86% | -181.10% +23.17% | -147.03% -4.33% | -153.68% -66.93% | |
Return on Equity | -169.18% -40.21% | -282.97% +20.98% | -233.90% +15.48% | -202.55% -71.32% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.78 -78.78% | 3.68 +246.77% | 1.06 -68.07% | 3.32 -21.67% | |
Cash Ratio | 0.61 -74.25% | 2.37 +376.75% | 0.50 -83.13% | 2.95 -22.11% | |
Debt-to-Equity Ratio | N/A N/A | 0.18 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | 0.13 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow